ESC 365 - Doctor Sean Zheng

Speaker illustration

Doctor Sean Zheng

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

Genome-wide association analysis reveals insights into the molecular etiology of dilated cardiomyopathy

Event: ESC Congress 2024

Topic: Cardiomyopathies

Session: Young Investigator Award Session in Population Science, Genetics and Epidemiology

Polygenic risk score for hypertrophic cardiomyopathy predicts population disease risk, penetrance in sarcomeric rare variant carriers and survival in cases

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Young Investigator Awards Session in Heart Failure

Cardiovascular outcomes with the incretin-based therapies GLP-1 agonists and DPP-4 inhibitors in type 2 diabetes participants with and without heart failure

Event: Heart Failure 2018

Topic: Diabetes and the Heart

Session: Moderated Poster session 3 - Novel treatment

Effects of aliskiren on mortality, cardiovascular outcomes and adverse events in diabetics with cardiovascular disease or risk: a systematic review and meta-analysis of 13,395 patients

Event: ESC Congress 2017

Topic: Diabetes, dysglycaemia and metabolic syndrome

Session: Diabetes mellitus: from "omics to complications"

Effect of drug treatment on quality of life in heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomised controlled trials

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: HFpEF - Heart failure with preserved ejection fraction

Session: HFpEF - Heart failure with preserved ejection fraction

Reporting quality of randomised controlled trials investigating efficacy of pharmacological therapies for heart failure with preserved ejection fraction

Event: HEART FAILURE 2016

Topic: HFpEF - Heart failure with preserved ejection fraction

Session: HFpEF - Heart failure with preserved ejection fraction

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources